Ha Noi - Hai Duong Beer JSC (HNX:HAD)
Vietnam · Delayed Price · Currency is VND 14,600
-1,200 (-7.59%)
At close: Aug 5, 2025
Sage Therapeutics Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 167,234 | 171,939 | 166,554 | 151,589 | 126,565 | 150,411 | Upgrade | |
Revenue Growth (YoY) | -1.02% | 3.23% | 9.87% | 19.77% | -15.85% | -4.18% | Upgrade |
Cost of Revenue | 127,976 | 132,419 | 131,538 | 109,287 | 97,609 | 111,225 | Upgrade |
Gross Profit | 39,258 | 39,520 | 35,016 | 42,302 | 28,957 | 39,186 | Upgrade |
Selling, General & Admin | 34,022 | 34,664 | 32,767 | 32,119 | 27,177 | 30,956 | Upgrade |
Operating Expenses | 34,022 | 34,664 | 32,767 | 32,119 | 27,177 | 30,956 | Upgrade |
Operating Income | 5,236 | 4,856 | 2,249 | 10,183 | 1,780 | 8,230 | Upgrade |
Interest & Investment Income | 3,465 | 3,061 | 5,231 | 2,876 | 2,084 | 1,696 | Upgrade |
Other Non Operating Income (Expenses) | 41.74 | 26.85 | 87.49 | 164.9 | -170.26 | -35.61 | Upgrade |
Pretax Income | 8,742 | 7,944 | 7,567 | 13,224 | 3,694 | 9,890 | Upgrade |
Income Tax Expense | 1,796 | 1,637 | 1,561 | 2,693 | 543.43 | 1,612 | Upgrade |
Net Income | 6,946 | 6,308 | 6,006 | 10,531 | 3,151 | 8,278 | Upgrade |
Preferred Dividends & Other Adjustments | 1,352 | 1,352 | 1,800 | - | - | - | Upgrade |
Net Income to Common | 5,594 | 4,955 | 4,206 | 10,531 | 3,151 | 8,278 | Upgrade |
Net Income Growth | 8.92% | 5.03% | -42.97% | 234.24% | -61.94% | -19.87% | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 4 | - | - | - | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 4 | - | - | - | Upgrade |
EPS (Basic) | 1398.44 | 1238.87 | 1051.45 | - | - | - | Upgrade |
EPS (Diluted) | 1398.44 | 1238.87 | 1051.00 | - | - | - | Upgrade |
EPS Growth | - | 17.88% | - | - | - | - | Upgrade |
Free Cash Flow | 48.27 | 6,388 | -1,817 | 11,134 | -1,155 | 17,233 | Upgrade |
Free Cash Flow Per Share | 12.07 | 1597.10 | -454.30 | - | - | - | Upgrade |
Dividend Per Share | - | - | - | - | 1000.000 | - | Upgrade |
Gross Margin | 23.47% | 22.98% | 21.02% | 27.91% | 22.88% | 26.05% | Upgrade |
Operating Margin | 3.13% | 2.82% | 1.35% | 6.72% | 1.41% | 5.47% | Upgrade |
Profit Margin | 3.35% | 2.88% | 2.53% | 6.95% | 2.49% | 5.50% | Upgrade |
Free Cash Flow Margin | 0.03% | 3.72% | -1.09% | 7.34% | -0.91% | 11.46% | Upgrade |
EBITDA | 10,096 | 10,119 | 7,673 | 16,155 | 9,529 | 16,519 | Upgrade |
EBITDA Margin | 6.04% | 5.88% | 4.61% | 10.66% | 7.53% | 10.98% | Upgrade |
D&A For EBITDA | 4,861 | 5,262 | 5,424 | 5,972 | 7,748 | 8,289 | Upgrade |
EBIT | 5,236 | 4,856 | 2,249 | 10,183 | 1,780 | 8,230 | Upgrade |
EBIT Margin | 3.13% | 2.82% | 1.35% | 6.72% | 1.41% | 5.47% | Upgrade |
Effective Tax Rate | 20.55% | 20.60% | 20.63% | 20.36% | 14.71% | 16.30% | Upgrade |
Revenue as Reported | 167,234 | 171,939 | 166,554 | 151,589 | 126,565 | 150,411 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.